about
Clinical features and predictors for disease natural progression in adults with Pompe disease: a nationwide prospective observational studyTreatment for postpolio syndromeTreatment for postpolio syndromeTreatment for postpolio syndromeMutations in the beta-tropomyosin (TPM2) gene--a rare cause of nemaline myopathyMutation update and genotype-phenotype correlations of novel and previously described mutations in TPM2 and TPM3 causing congenital myopathiesEarly onset neuropathy in a compound form of Charcot-Marie-Tooth diseaseThe history of progressive muscular atrophy: syndrome or disease?Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2
P50
Q21202855-DB44C67F-9765-4FB3-9F99-B426CFE83A56Q24187934-4066C3D6-86E8-4617-925B-669DF1EF4944Q24236577-7FB3F4F8-A24E-47E8-A777-F495A9B58F77Q24240648-8CC4D8B0-81AB-4644-AD76-ACF7524D4720Q28209824-8B05C73D-EEE5-46A9-899B-C71024869775Q28237280-290AD313-08B2-4CF7-B3BB-AC4AD531989BQ28241413-2E8F55D9-7A14-47C9-BAF5-BD6F006C9CB9Q28270105-A89EC754-AF3B-4820-89F6-14EC472446D2Q29303884-1004B0FA-3C79-4EEF-8433-05F0952CA2B7
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Marianne de Visser
@ast
Marianne de Visser
@en
Marianne de Visser
@es
Marianne de Visser
@nl
Marianne de Visser
@sl
type
label
Marianne de Visser
@ast
Marianne de Visser
@en
Marianne de Visser
@es
Marianne de Visser
@nl
Marianne de Visser
@sl
prefLabel
Marianne de Visser
@ast
Marianne de Visser
@en
Marianne de Visser
@es
Marianne de Visser
@nl
Marianne de Visser
@sl